Research Units operated under the DFG’s umbrella provide an invaluable framework by which scientists can pursue focused lines of investigation, often exploring innovative and sometimes risky research directions over extended periods of up to eight years. This durability encourages continuity, depth, and the cumulative building of knowledge, which is critical in addressing multifaceted scientific questions. Currently, the DFG sustains a vibrant ecosystem comprising 188 Research Units, alongside ten Clinical Research Units and 17 dedicated Centres for Advanced Studies in Humanities and Social Sciences. These entities are carefully structured to tailor their research environments according to disciplinary needs: Clinical Research Units emphasize the symbiosis of research and clinical applications, whereas Humanities Centres provide supportive contexts conducive to intellectual inquiry specific to their fields.

One of the newly inaugurated Research Units delves into the cognitive intricacies of bilingualism, an area of escalating scientific and societal significance. This unit, aptly named “Bilingual Flexibility – The Psychology of Language Control,” investigates the mechanisms employed by bilingual individuals who adeptly navigate between multiple languages. The central hypothesis explores the concept of “language balance,” a dynamic cognitive equilibrium that bilingual speakers maintain to select the appropriate linguistic code for varying contexts while inhibiting interference from alternative languages. By applying rigorous psychological methodologies, this unit seeks to unveil how language control mechanisms stabilize this balance, enabling nuanced communication across diverse environments. This research not only advances theoretical models of bilingual cognition but also informs practical applications in education and sociolinguistics.

In an era marked by escalating geopolitical tensions and ecological disturbances, the second new Research Unit interrogates the evolving meanings and assurances of security. Titled “The Promise of Security in Catastrophic Times,” this research conglomerate adopts interdisciplinary lenses to scrutinize the unraveling certainties surrounding peace and democratic governance worldwide. It specifically focuses on the interplay of three intensifying and interlinked crises: a surge in armed conflicts and wars, the alarming global slide toward autocratic governance models, and the accelerating ecological emergency. By choreographing collaborative efforts across political science, sociology, environmental studies, and related disciplines, the unit aims to unpack how societies and governments respond, adapt, or fail in the face of these compounding existential threats, thereby contributing foundational insights for policy and theoretical refinement.

The third Research Unit embarks on possibly life-saving scientific inquiry into colorectal cancer, which represents a substantial burden globally due to its prevalence and mortality rates. The unit, known as “Functional Genomics and Microbiomics in Precision Medicine of Colorectal Cancer (GenoMiCC),” seeks to transcend the current limitations of genome-based precision medicine. Existing therapies typically hinge on DNA sequencing to tailor treatments; however, these approaches have proven efficacious only for a minority of patients. GenoMiCC aims to dissect the intricate relationships among the gut microbiome, tumor-associated genetic alterations, and pharmacological interventions. This comprehensive systems biology approach aspires to pioneer personalized, microbiome-informed therapies that could markedly improve survival and treatment responsiveness in colorectal cancer patients. Importantly, this initiative benefits from D-A-CH cooperation, reflecting a synergistic scientific alliance between German and Swiss research institutions.

Exploring a different domain, a fourth Research Unit titled “Times of Rise and Failure (TORF)” undertakes a historical-ecological analysis of North Frisia’s cultural landscape between the 12th and 14th centuries. Through integrating archaeological, environmental, and historical data, TORF reconstructs the ways inhabitants engineered the natural environment to foster a productive yet fragile cultural ecosystem. Their intensive anthropogenic modifications, such as dike constructions and land reclamation, were repeatedly tested by devastating storm surges that reshaped the tidal flats. By scrutinizing human-environment interactions over centuries, this research illuminates medieval strategies for resource security, settlement expansion, and resilience to environmental threats. The outcomes are poised to enrich understanding of cultural heritage conservation and offer analogs for contemporary coastal management amidst climate change.

Beyond these groundbreaking new units, the DFG has also extended funding for ten ongoing Research Units and one Clinical Research Unit, cementing sustained inquiry into critical and diverse scientific topics. These established units encompass a broad spectrum of disciplines and challenges, ranging from condensed matter physics — evidenced by the Research Unit exploring proximity-induced correlation effects in low-dimensional systems — to ecosystem science, with the unit investigating the resilience and reassembly of species interaction networks in rainforest ecosystems. This breadth demonstrates the DFG’s appreciation for a research portfolio that balances fundamental physics with applied ecological studies, both essential for understanding and innovating within natural and technological systems.

Extending into material science and engineering, one Research Unit focuses on the phenomenon of solidification cracks occurring during laser beam welding processes, deploying high-performance computing tools to simulate and optimize these manufacturing phenomena. This confluence of experimental and computational research is crucial for advancing precision manufacturing technologies, which underpin numerous industrial applications from aerospace to biomedical device production. Similarly, the Research Unit on nonequilibrium systems addresses the complexity inherent in systems far from thermodynamic equilibrium, a fundamental challenge in theoretical and applied physics with implications for nanotechnology and materials science.

Other extensions include units dedicated to social sciences and humanities. The unit on “Reconfiguration and Internalization of Social Structure (RISS)” investigates dynamic social structures and their influence on individual and collective behavior, contributing to sociology’s understanding of social stratification and change. Likewise, the unit on “Spiritual Intermediality in the Early Modern Period” explores how early modern religious practices and communication were shaped by media and intermedial transfers, thereby enriching cultural and historical scholarship.

In the life sciences, research continues apace on plant reproductive biology through the “Innovation and Coevolution in Plant Sexual Reproduction (ICIPSS)” unit, exploring evolutionary dynamics driving plant diversity and adaptation. Clinical research maintains its critical focus with the extension of the Clinical Research Unit “CATCH ALL,” dedicated to finding curative strategies for acute lymphoblastic leukemia across age groups. This translational research fuses molecular biology and clinical application to address pressing medical challenges.

Overall, the DFG’s strategic mix of establishing new Research Units while extending successful ones creates a vibrant research ecosystem that nurtures long-term, high-impact studies. Its emphasis on interdisciplinary collaboration, international partnerships, and integration of cutting-edge methods positions German research at the forefront of addressing global scientific and societal challenges. Such investments reflect a forward-looking vision that not only advances knowledge but also facilitates innovation, education, and informed policy development.

For media and scholarly inquiries, the DFG provides access to network spokespersons and contact persons specializing in quality and programme management, underscoring its commitment to transparency and engagement with the scientific community. This openness ensures that research findings are disseminated widely and can inspire further questions and collaborations necessary for the continued evolution of science.

The Deutsche Forschungsgemeinschaft’s latest funding decisions thus represent a significant step in reinforcing Germany’s vibrant scientific landscape, supporting scholars engaged in decoding the complexities of human language, societal security, disease mechanisms, and cultural history. This expansion reflects a broader trend within global research funding agencies to back ambitious, collaborative projects that promise both foundational insights and practical applications in an increasingly interconnected and challenging world.

Subject of Research: Multidisciplinary investigation encompassing bilingual language control, global security crises, precision medicine for colorectal cancer, medieval cultural landscape dynamics, and extensions in condensed matter physics, ecology, social sciences, humanities, material science, and clinical leukemia research.

Article Title: DFG Launches Four Innovative Research Units and Extends Ten Critical Programs to Advance Science Across Disciplines

News Publication Date: Not explicitly specified, refer to DFG announcement date.

Web References:

• DFG Centres for Advanced Studies in Humanities and Social Sciences

Keywords: Scientific community, Science policy, Scientific method, Scientific organizations, Scientific publishing, Research programs

Queuosine is a unique and elusive molecule classified as a vitamin-like micronutrient. First isolated in the 1970s, it remains one of the most mysterious compounds in human biology, in part because humans lack the biosynthetic machinery to produce it endogenously. Instead, queuosine is acquired exclusively through dietary sources and the metabolic activities of the gut microbiota. Despite being indispensable for various physiological processes, the complexities of how queuosine enters and functions within human cells have largely eluded scientific scrutiny until now.

The recent study, published in the prestigious journal Proceedings of the National Academy of Sciences (PNAS), unveils that the human gene SLC35F2 encodes the key transporter protein responsible for the cellular import of queuosine. This transporter facilitates the assimilation of queuosine into cells, enabling it to perform its critical role as a post-transcriptional modification to transfer RNA (tRNA). The modification fine-tunes the cellular translation machinery, ensuring genetic information is accurately decoded into functional proteins. Errors in this process are associated with numerous diseases, highlighting the importance of understanding the pathways that govern queuosine availability.

Professor Vincent Kelly from Trinity College Dublin, senior author of the study, emphasized the transformative nature of this discovery. “For years, we knew queuosine played essential roles in brain health, metabolic regulation, cancer biology, and stress responses," he explained. “Yet, how this molecule journeyed from the gut environment, where it is sourced, to the billions of cells in the human body remained a mystery. Identifying SLC35F2 as the queuosine transporter bridges this knowledge gap and opens vast research opportunities.”

Until now, the inability to pinpoint how queuosine crosses cell membranes had hampered efforts to unravel its full biological significance. The identification of SLC35F2 as a conserved transporter demonstrates an ancient, evolutionarily preserved mechanism present in organisms ranging from simple unicellular life forms to humans. This evolutionary conservation underscores queuosine’s foundational role across diverse life forms and signals potential broader biological implications beyond what was previously envisioned.

Leading the investigations from the University of Florida, Professor Valérie de Crécy-Lagard conveyed the anticipation that this breakthrough engenders within the scientific community. “Scientists have long suspected the presence of a queuosine transporter,” she stated. “We have pursued this target extensively, understanding that queuosine influences how the microbiome and diet intertwine with gene expression. This discovery fundamentally redefines our concept of nutrient-gene interactions.”

Mechanistically, queuosine’s integration into tRNA molecules enhances the fidelity and efficiency of protein synthesis, a cellular process crucial for maintaining homeostasis and responding to environmental stimuli. Aberrations in tRNA modification patterns, including queuosine deficiency, are implicated in cancer progression, neurological disorders, and metabolic syndromes. Thus, elucidating the molecular machinery behind queuosine transport has immediate relevance to developing novel diagnostic and therapeutic approaches.

Compellingly, the SLC35F2 gene had been previously examined in the context of viral entry and chemotherapeutic drug uptake, yet its physiological role in nutrient transport remained undefined. This newfound function reveals a dual relevance of the gene in both health and disease conditions. Researchers are now poised to investigate how modulation of SLC35F2 activity might influence susceptibility to diseases or responsiveness to treatments, especially in oncology and neurology.

The intersection of microbiota-derived nutrients and host cellular machinery epitomized by queuosine also highlights the broader impact of diet and microbial ecology on human biology. This study exemplifies the intricate symbiosis between humans and their microbiome, where microbial metabolites act as essential cofactors in fundamental cellular processes. Future research will likely delve into how variations in gut microbial populations affect queuosine availability and consequently human health.

The therapeutic potential borne out of this research is substantial. By targeting the queuosine transport pathway, it may be possible to engineer interventions that amplify its beneficial effects or mitigate pathological processes linked to its deficiency. For instance, enhancing queuosine uptake in neurons might bolster cognitive function or delay neurodegenerative decline, while manipulating its role in cancer cells could improve therapeutic outcomes.

Furthermore, the discovery encourages a reassessment of dietary guidelines and nutritional supplementation strategies. Given that queuosine cannot be synthesized by humans, understanding its absorption mechanism empowers nutritionists and clinicians to more precisely tailor diets or develop supplements that optimize queuosine levels, potentially fortifying brain health and immune resilience.

In summary, the identification of SLC35F2 as the transporter responsible for queuosine uptake is a landmark achievement in molecular and nutritional sciences. This advancement bridges a critical divide in our understanding of micronutrient biology, from gut symbionts to cellular function, and paves the way for innovative research and therapy development. As scientific exploration continues, the small but mighty queuosine molecule may emerge as a key player in governing human health and disease, driven by the newly revealed molecular gateway that ushers it into our cells.

Subject of Research: Queuosine nutrient uptake and tRNA modification in human cells

Article Title: Identification of SLC35F2 as the human queuosine transporter facilitating tRNA modification

News Publication Date: 2024

Web References:
10.1073/pnas.2425364122

References:
Proceedings of the National Academy of Sciences (PNAS), 2024

Keywords: Queuosine, tRNA modification, micronutrient transport, SLC35F2, gene expression, protein synthesis, microbiome, cancer suppression, brain function, molecular biology, nutrient-gene interaction

A collaborative team from esteemed institutions, including the Wellcome Sanger Institute, Imperial College London, and Harvard University, spearheaded this research, employing cutting-edge CRISPR prime editing techniques. The researchers utilized these advanced genome-editing technologies to produce diverse versions of human genomes, which were subjected to sequencing in order to assess the implications of structural variances on cell viability. This harrowing interdisciplinary work was documented in a recent publication in the prestigious journal Science.

The conclusive findings of this research indicate that as long as vital genes are preserved in their entirety, human genomes can not only withstand but also adapt to substantial structural changes like large deletions or alterations in the DNA sequence. This resilience suggests that structural variations may play a more complex role in human health than previously understood, opening avenues for researchers to investigate how such changes contribute to disease.

Structural variation is not simply a minor adjustment; it encompasses profound changes within an organism’s genome, which may include large sections of deletions, duplications, or inversions of the genetic code. These alterations can span large segments, affecting countless nucleotides—the fundamental components of DNA and RNA. While historical associations have been drawn between structural variants and various developmental disorders and types of cancer, the true complexity of these genetic modifications in mammals has remained elusive—largely attributable to previous technological limitations in engineering and studying these changes.

In the face of this challenge, the researchers at the Sanger Institute opted to innovate. They ingeniously combined both CRISPR prime editing and human cell lines to instigate the genesis of expansive structural variants within a single experimental framework. Central to this endeavor was the insertion of specific recognition sequences into the genomes, designed to be targeted using recombinase—an enzyme that facilitated the systematic shuffling of the genome.

By implanting these recombinase handles into repetitive DNA sequences, researchers were able to distribute nearly 1,700 recognition sites across each human cell line, effectively creating more than 100 random large-scale genetic alterations in each instance. This pioneering experiment is distinctive for its success in ‘shuffling’ a mammalian genome at an unprecedented scale, marking a monumental leap in the field of genetic engineering.

Continuous monitoring allowed the scientists to trace the impacts of these structural variations over a few weeks. By employing genomic sequencing techniques, they captured periodic ‘snapshots’ of the modified human cell lines, tracking their survival and proliferation. Expectedly, when genes deemed essential were deleted, those cell lines exhibited a detrimental selection, resulting in cell death. In contrast, cell populations that experienced extensive genetic deletions, while sparing critical gene segments, demonstrated survival, underscoring the potential for adaptability within our genetic framework.

Further investigation involved RNA sequencing to glean insights into gene activity—often characterized as gene expression—among these human cell lines. The results revealed an intriguing aspect: large-scale deletions, especially those occurring in non-coding regions of DNA, appeared not to disrupt the overall gene expression profile of the cells. This observation suggests that substantial segments of non-coding DNA might be effectively superfluous to cellular function and stability, prompting vital questions regarding the actual role of non-coding regions in genomic architecture.

The researchers proposed that human genomes boast an extraordinary aptitude for coping with structural variations, including substantial repositioning of numerous genes, provided that essential genetic content remains untouched. Moreover, they raised a compelling hypothesis about the dispensability of much non-coding DNA in human genomes. However, they emphasized the need for further investigations to corroborate or refute these nascent ideas through additional experimental deletions across a broader array of cell lines.

In conjunction with their study, another research group from the University of Washington explored similar objectives, focusing on generating structural variants en masse and discerning their impacts on the human genome. Utilizing a different strategy, this team integrated recombinase sites with transposons—dynamic genetic elements—that spontaneously inserted into the genomes of human cell lines and mouse embryonic stem cells. Their findings indicate that the consequences of these induced structural variants can be discerned using single-cell RNA sequencing techniques. This advancement could facilitate more extensive screenings of structural variant implications, refining the classification of variations observed in human genetic datasets as benign or potentially harmful.

Both research groups converged on similar conclusions, as their endeavors unveiled a shared realization that human genomes can astonishingly accommodate considerable structural changes. However, the extensive range of possible adaptations and tolerances manifested by these genomes warrants additional research, which may well enable future studies using the pioneering methodologies established in these papers.

Ultimately, this research epitomizes a quantum leap in the engineering of human cell lines, ushering in a new era of genomic exploration. For the first time, the ability to create substantial structural variants within human genomes via large-scale methodologies in a single experiment is now a tangible reality. Such advancements will not only deeply enhance our comprehension of structural variations and their relevance to disease but may also pave the way for predictive models regarding the potential dangers posed by these genomic alterations in individual contexts.

This newly harnessed technology could yield entirely novel, optimized cell lines tailored for specific purposes, including enhanced growth rates or studied responses to various therapies. The potential applications stretch far beyond mere experimentation, hinting at the possibility of bioengineering cells to yield therapeutic agents essential for future medical breakthroughs.

As Dr. Jonas Koeppel, a lead author of the study, articulated, if the genome is envisioned as a book where a single nucleotide alteration is likened to a typographical error, then structural variations resemble the act of removing an entire page. These complex genetic variations often play consequential roles in developmental anomalies and oncogenesis, yet studying them has traditionally presented formidable challenges. The collaborative ingenuity that birthed this monumental study has surmounted significant barriers, allowing for a flexible and robust exploration of human genetic variability.

This collaboration exemplifies the extraordinary convergence of advancements across multiple scientific disciplines, fueled by synergic efforts across international frameworks. The optimal synthesis of genomic sequencing capabilities, state-of-the-art engineering methods, and innovative recombinase applications lays fertile ground for driving future genetic research forward. Among the many tantalizing possibilities lies the chance to unravel the mysteries of structural variation in genome-associated diseases, with an eye towards novel therapeutic interventions.

The study ultimately underscores an exhilarating frontier in genomic science, one that could redefine our understanding of both the resilience of human genetics and the potential for profound implications in clinical research and biomedical engineering.

Subject of Research: Structural Variations in Human Genomes
Article Title: Randomizing the human genome by engineering recombination between repeat elements
News Publication Date: 31-Jan-2025
Web References: Wellcome Sanger Institute – Imperial College London – Harvard University
References: Sudarshan Pinglay et al. (2025) ‘Multiplex generation and single cell analysis of structural variants in mammalian genomes.’ Science. DOI: 10.1126.science.ado5978
Image Credits: Wellcome Sanger Institute

Keywords

Gene editing, Structural variation, Genome tolerance, CRISPR technology, Human genetics, Genome engineering, RNA sequencing, Genomic research, Cell line optimization, Disease modeling, Biomedical applications, Collaborative science.